The largest ever clinical trial of T cell therapy for solid tumours has ended, heralding a new era for precision T cell ...

Among the 65 analysts that follow Nvidia, 92% rate the stock a buy. The median price target of $150 per share implies 2% upside from its current share price of $147. Among the 70 analysts that follow ...

The stock market set fresh records on Friday, with the Dow Jones and S&P 500 concluding their strongest week in a year after Donald Trump’s election victory. The Dow Jones Industrial Average climbed ...

Lower taxes would be a boon for an equity market that was starting to look priced for perfection, but tariffs could create longer-term damage.

Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...

The Zacks Diversified Operations industry is poised to benefit from strength across aerospace, defense, and oil & gas ...

Affordable getaways are easily within reach if you know where to look. We've got the best cheap places to travel around the ...

If they stay true to form, it seems likely Gopinath may be groomed to join him as a comanager at some point down the line. The broader ... employee-owned firm has a solid core, with flagship ...

The analysts follow the firm's typical growth approach, looking for companies with strong returns on invested capital and solid balance ... below the 53% median of other large-growth Morningstar ...

50%, p<0.001) and improvement in overall survival (median: 16 months vs ... "These real-world results across multiple solid tumor types should empower plans to cover CGP as a first-line test." ...